Pharmacists in Camden, South Carolina


29 Pharmacists found in Camden
female pharmacist

Mrs. Katherine L Johnson, PHARMD


Pharmacist
2209 W Dekalb St, Camden, SC 29020
803-425-9527    

female pharmacist

Dr. Kimberly Williams, PHARMD


Pharmacist
2407 Broad St, Camden, SC 29020
803-424-2510    

female pharmacist

Laney Allen Hodges, PHARMD


Pharmacist
2407 Broad St, Camden, SC 29020
803-424-2510     803-424-2542



female pharmacist

Laura Hooks


Pharmacist
2240 W Dekalb St, Camden, SC 29020
803-425-1691     803-425-4096

female pharmacist

Mrs. Mary Sue Morrison, RPH


Pharmacist
2209 W Dekalb St, Camden, SC 29020
803-425-9527    

male pharmacist

Mr. Nicholas R. Gross


Pharmacist
1023a W Dekalb St, Camden, SC 29020
803-424-0064     803-424-0065

female pharmacist

Regina Mcqueen, PHARMD


Pharmacist
811 W Dekalb St, Camden, SC 29020
803-432-4646    

male pharmacist

Robert B Davis, PHARMD, MS


Pharmacist
2407 Broad St, Camden, SC 29020
803-424-2510     803-424-2542

male pharmacist

Mr. Roger Zane Frick, RPH


Pharmacist
2209 W Dekalb St, Camden, SC 29020
803-425-9527     803-425-9188

female pharmacist

Sharon Brown


Pharmacist
1521 Jefferson Davis Hwy, Camden, SC 29020
803-425-8240     803-425-8241

male pharmacist

Mr. Steven J Jones, RPH


Pharmacist
2534 Broad St, Camden, SC 29020
803-427-4442     803-425-8462

female pharmacist

Dr. Tava T. Cunningham, PHARMD


Pharmacist
1023a Dekalb St, Camden, SC 29020
803-424-0064    

male pharmacist

Mr. William Grant Freeman, RPH


Pharmacist
1521 Jefferson-davis Hwy, Camden, SC 29020
803-425-8244    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.